Patents by Inventor Liselotte Bjerre Knudsen

Liselotte Bjerre Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Regulation of food preference using GLP-1 agonists
    Patent number: 9486504
    Abstract: GLP-1 agonists selectively decrease the amount of food intake, wherein the food has a high glycemic index or wherein the amount of mono- and di-saccharides together constitute a large proportion of the total amount of carbohydrates.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: November 8, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Kirsten Raun, Pia Von Voss, Liselotte Bjerre Knudsen, Kjell Malmlöf
  • GLP-1 AGONIST AND CARDIOVASCULAR COMPLICATIONS
    Publication number: 20140206615
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 24, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-1 Agonist and Cardiovascular Complications
    Publication number: 20130338071
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: August 26, 2013
    Publication date: December 19, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20120295836
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: April 4, 2012
    Publication date: November 22, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Patent number: 8158583
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: April 17, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Bøving, Morten Schlein
  • Derivatives of GLP-1 analogs
    Patent number: 8097698
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Grant
    Filed: November 26, 2007
    Date of Patent: January 17, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Soren Erik Bjorn, Freddy Zimmerdahl Pedersen, Kjeld Madsen
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20110230409
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: June 2, 2011
    Publication date: September 22, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-1 Derivatives II
    Publication number: 20110053839
    Abstract: The present invention relates to a derivative of GLP-1(7-C), wherein C is 35 or 36 which derivative has just one lipophilic substituent which is attached to the C-terminal amino acid residue.
    Type: Application
    Filed: August 23, 2010
    Publication date: March 3, 2011
    Applicant: NOVO NORDISK A/S
    Inventors: LISELOTTE BJERRE KNUDSEN, PER OLAF HUUSFELDT, PER FRANKLIN NIELSEN, KJELD MADSEN
  • Use of GLP-1 Peptides
    Publication number: 20110028391
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: October 15, 2010
    Publication date: February 3, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Regulation of Food Preference Using GLP-1 Agonists
    Publication number: 20100222277
    Abstract: GLP-1 agonists selectively decrease the amount of food intake, wherein the food has a high glycemic index or wherein the amount of mono- and di-saccharides together constitute a large proportion of the total amount of carbohydrates.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: KIRSTEN RAUN, PIA VON VOSS, LISELOTTE BJERRE KNUDSEN, KJELL MALMLÖF
  • Use of GLP-1 Peptides
    Publication number: 20100113363
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: January 4, 2010
    Publication date: May 6, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia
    Publication number: 20090286716
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 19, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Boving, Morten Schlein
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20090215688
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: June 5, 2008
    Publication date: August 27, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • Derivatives Of GLP-1 Analogs
    Publication number: 20090176700
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Application
    Filed: November 26, 2007
    Publication date: July 9, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Soren Erik Bjorn, Freddy Zimmerdahl Pedersen, Kjeld Madsen
  • Use of GLP-1 Peptides
    Publication number: 20090149387
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: February 12, 2009
    Publication date: June 11, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Lowering Serum Lipids
    Publication number: 20080280815
    Abstract: The present invention relates to a method for lowering serum lipids, eg. triglycerides and/or cholesterol in a subject comprising administering a GLP-1 agonist to said subject.
    Type: Application
    Filed: August 22, 2007
    Publication date: November 13, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Johan Selmer, Jeppe Sturise, Philip Just Larsen
  • GLP-1 derivatives II
    Publication number: 20080103097
    Abstract: The present invention relates to a derivative of GLP-1(7-C), wherein C is 35 or 36 which derivative has just one lipophilic substituent which is attached to the C-terminal amino acid residue.
    Type: Application
    Filed: April 26, 2007
    Publication date: May 1, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Kjeld Madsen
  • Extendin derivatives
    Patent number: 7226990
    Abstract: The present invention relates to novel derivatives of exendin-4 or exendin-4 fragments, wherein the derivatives have a lipophilic substituent attached, optionally via a spacer, to an amino acid residue, which is not the N-terminal or C-terminal amino acid residue of the derivative.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: June 5, 2007
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Kjeld Madsen
  • Non-peptide GLP-1 agonists
    Patent number: 6927214
    Abstract: Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an activation of the human GLP-1 receptor is beneficial, especially metabolic disorders such as IGT, Type 1 diabetes, Type 2 diabetes and obesity.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: August 9, 2005
    Assignee: Novo Nordisk A/S
    Inventors: Min Teng, Larry Kenneth Truesdale, Dilip Bhumralkar, Dan Kiel, Michael D. Johnson, Christine Thomas, Anker Steen Jorgensen, Peter Madsen, Preben Houlberg Olesen, Liselotte Bjerre Knudsen, Ingrid Vivika Petterson, Johannes Cornelis de Jong, Carsten Behrens, Janos Tibor Kodra, Jesper Lau
  • GLP-2 derivatives
    Publication number: 20040127418
    Abstract: Analogs of GLP-2, pharmaceutical compositions comprising GLP-2 analogs, and methods of treating diseases and disorders comprising administering such analogs or compositions are provided.
    Type: Application
    Filed: December 8, 2003
    Publication date: July 1, 2004
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Lars Thim, Soren Erik Bjorn